Charles River Laboratories Announces Third-Quarter 2018 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Charles River Labs (CRL) PT Raised to $147 at RBC Capital
November 8, 2018 7:01 AM ESTRBC Capital analyst George Hill raised the price target on Charles River Labs (NYSE: CRL) to $147.00 (from $131.00) while maintaining an Outperform rating following Q3 results, which beat on EPS and revenue though margin missed.
"We believe the miss was largely a... More
Charles River Laboratories (CRL) Tops Q3 EPS by 15c
November 7, 2018 7:03 AM ESTCharles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.53, $0.15 better than the analyst estimate of $1.38. Revenue for the quarter came in at $585.3 million versus the consensus estimate of $567.79 million.
GUIDANCE:
Charles River Laboratories sees FY2018 EPS of $5.87-$5.97, versus the... More
